163 related articles for article (PubMed ID: 32164064)
21. HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis.
Zhang DW; Zhao YX; Wei D; Li YL; Zhang Y; Wu J; Xu J; Chen C; Tang H; Zhang W; Gong L; Han Y; Chen ZN; Bian H
J Hepatol; 2012 Dec; 57(6):1283-91. PubMed ID: 22878468
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells.
González-Fernández B; Sánchez DI; Crespo I; San-Miguel B; Álvarez M; Tuñón MJ; González-Gallego J
Biofactors; 2017 Mar; 43(2):272-282. PubMed ID: 27801960
[TBL] [Abstract][Full Text] [Related]
23. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W
Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855
[TBL] [Abstract][Full Text] [Related]
24. Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice.
Senoo T; Sasaki R; Akazawa Y; Ichikawa T; Miuma S; Miyaaki H; Taura N; Nakao K
BMC Gastroenterol; 2018 Feb; 18(1):34. PubMed ID: 29486718
[TBL] [Abstract][Full Text] [Related]
25. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
[TBL] [Abstract][Full Text] [Related]
26. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
[TBL] [Abstract][Full Text] [Related]
27. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice.
Lamb CL; Cholico GN; Pu X; Hagler GD; Cornell KA; Mitchell KA
Toxicol Appl Pharmacol; 2016 Nov; 311():42-51. PubMed ID: 27693115
[TBL] [Abstract][Full Text] [Related]
28. Celecoxib derivative OSU-03012 inhibits the proliferation and activation of hepatic stellate cells by inducing cell senescence.
Zhang J; Wang M; Zhang Z; Luo Z; Liu F; Liu J
Mol Med Rep; 2015 Apr; 11(4):3021-6. PubMed ID: 25482718
[TBL] [Abstract][Full Text] [Related]
29. Anti-fibrotic effect of thymoquinone on hepatic stellate cells.
Ghazwani M; Zhang Y; Gao X; Fan J; Li J; Li S
Phytomedicine; 2014 Feb; 21(3):254-60. PubMed ID: 24182989
[TBL] [Abstract][Full Text] [Related]
30. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
31. Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells.
Zhang D; Zhang L; Chen G; Xu Y; Yang H; Xiao Z; Chen J; Mu Y; Zhang H; Liu W; Liu P
Pharm Biol; 2020 Dec; 58(1):1229-1243. PubMed ID: 33332219
[TBL] [Abstract][Full Text] [Related]
32. Relaxin decreases the severity of established hepatic fibrosis in mice.
Bennett RG; Heimann DG; Singh S; Simpson RL; Tuma DJ
Liver Int; 2014 Mar; 34(3):416-26. PubMed ID: 23870027
[TBL] [Abstract][Full Text] [Related]
33. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
Chen W; Zhang Z; Yao Z; Wang L; Zhang F; Shao J; Chen A; Zheng S
Int Immunopharmacol; 2018 Mar; 56():148-155. PubMed ID: 29414645
[TBL] [Abstract][Full Text] [Related]
34. Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway.
Sun WY; Song Y; Hu SS; Wang QT; Wu HX; Chen JY; Wei W
J Cell Biochem; 2013 May; 114(5):1153-62. PubMed ID: 23192415
[TBL] [Abstract][Full Text] [Related]
35. Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell.
Ai WL; Dong LY; Wang J; Li ZW; Wang X; Gao J; Wu Y; An W
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3780-3791. PubMed ID: 30251695
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-146a-5p Attenuates Fibrosis-related Molecules in Irradiated and TGF-beta1-Treated Human Hepatic Stellate Cells by Regulating PTPRA-SRC Signaling.
Yuan BY; Chen YH; Wu ZF; Zhuang Y; Chen GW; Zhang L; Zhang HG; Cheng JC; Lin Q; Zeng ZC
Radiat Res; 2019 Dec; 192(6):621-629. PubMed ID: 31560641
[TBL] [Abstract][Full Text] [Related]
37. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
38. A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis.
Shi MJ; Yan XL; Dong BS; Yang WN; Su SB; Zhang H
J Ethnopharmacol; 2020 May; 253():112689. PubMed ID: 32101775
[TBL] [Abstract][Full Text] [Related]
39. A novel flow cytometry tool for fibrosis scoring through hepatic stellate cell differentiation.
Amer J; Salhab A; Doron S; Morali G; Safadi R
Cytometry A; 2018 Apr; 93(4):427-435. PubMed ID: 29517852
[TBL] [Abstract][Full Text] [Related]
40. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
Yi HS; Eun HS; Lee YS; Jung JY; Park SH; Park KG; Choi HS; Suh JM; Jeong WI
PLoS One; 2015; 10(5):e0127946. PubMed ID: 26024318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
